Narsoplimab-wuug (Yartemlea)
Dilution requiredFull monograph review pending
U.S. label preparation
Yartemlea · Dilution required
- Preparation
- Use 5% dextrose. For adults and pediatric patients weighing at least 10 kg, prepare a PVC bag at 0.8-8 mg/mL. For pediatric patients under 10 kg, use a polypropylene syringe at 0.8 mg/mL.
- Administration and handling
- Both preparations have a 50 mL maximum volume. Use the specified 0.2-micron PES filter, tubing and catheter.
Product and source details
Omeros Corporation · BLA761152
Product NDC: 62225-300
SPL effective 2026-01-20 | SPL version 6. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.